Dainippon Sumitomo Pharma Co., Ltd. Acquires Sepracor Inc.

Download IconDownload Print IconPrint

Dainippon Sumitomo Pharma Co., Ltd. Acquires Sepracor Inc.

Firm News

Related Solutions

WilmerHale lawyers have decades of experience advising public and private companies in all aspects of mergers and acquisitions.

Dainippon Sumitomo Pharma Co., Ltd. (DSP) and Sepracor Inc. recently announced the successful completion of DSP’s acquisition of Sepracor for approximately $2.6 billion.

DSP completed the acquisition through a cash tender offer and by exercising an option to acquire additional shares directly from Sepracor followed by a short-form merger of an indirect wholly-owned subsidiary of DSP with and into Sepracor on October 20, 2009. Sepracor is now an indirect wholly-owned subsidiary of DSP.

WilmerHale represented Sepracor in this matter. The WilmerHale team was led by Partners Hal Leibowitz and Susan Murley and included Lia Der Marderosian, Brett Budzinski, Stephen Ranere and John Harrison.

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel